BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6423357)

  • 1. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
    Nitsch J; Lüderitz B
    Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring amiodarone].
    Glasson S; Bron D; Payot M; Schelling JL
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1731-2. PubMed ID: 6658417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and red blood cell concentrations of amiodarone during chronic therapy.
    Heger JJ; Solow EB; Prystowsky EN; Zipes DP
    Am J Cardiol; 1984 Mar; 53(7):912-7. PubMed ID: 6538381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study].
    Escoubet B; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1046-52. PubMed ID: 3929732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone.
    Manfredi C; Clerico A; Iervasi G; Turchi S; Cazzuola F; Berti S; Sabatino L; Biagini A
    Int J Clin Pharmacol Res; 1995; 15(2):87-93. PubMed ID: 8593976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects during therapy with low dosage amiodarone.
    Landolina M; Beck Peccoz P; Piscitelli G; Maggioni AP; Volpi A; Galletti F; Tognoni G; Ferrario G; Giani P
    G Ital Cardiol; 1984 Sep; 14(9):723-6. PubMed ID: 6510626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
    Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
    Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
    Lüderitz B; Manz M; Steinbeck G
    Dtsch Med Wochenschr; 1983 Nov; 108(44):1663-7. PubMed ID: 6414795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration response relationships of amiodarone and desethylamiodarone.
    Connolly SJ; Gupta RN; Hoffert D; Roberts RS
    Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels.
    Kannan R; Yabek SM; Garson A; Miller S; McVey P; Singh BN
    Am Heart J; 1987 Aug; 114(2):283-7. PubMed ID: 3604884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.